Loss of receptor activity-modifying protein 3 exacerbates cardiac hypertrophy and transition to heart failure in a sex-dependent manner

This publication has 63 references indexed in Scilit:

• Estrogen, hormonal replacement therapy and cardiovascular disease
  Current Opinion in Nephrology and Hypertension, 2011
• Mechanism of Cardioprotection: What Can We Learn from Females?
  Pediatric Cardiology, 2011
• Mid-Regional Pro-Adrenomedullin as a Novel Predictor of Mortality in Patients with Chronic Heart Failure
  European Journal of Heart Failure, 2010
• Molecular Basis of Association of Receptor Activity-Modifying Protein 3 with the Family B G Protein-Coupled Secretin Receptor
  Biochemistry, 2009
• Mid-Regional Pro-Adrenomedullin Is Associated With Pulse Pressure, Left Ventricular Mass, and Albuminuria in African Americans With Hypertension
  American Journal of Hypertension, 2009
• Using Basic Science to Design a Clinical Trial: Baseline Characteristics of Women Enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)
  Journal of Cardiovascular Translational Research, 2009
• Mice heterozygous for adrenomedullin exhibit a more extreme inflammatory response to endotoxin-induced septic shock
  Peptides, 2007
• Inhibition of Apoptosis-Regulated Signaling Kinase-1 and Prevention of Congestive Heart Failure by Estrogen
  Circulation, 2007
• Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males
  Proceedings of the National Academy of Sciences, 2007
• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002